Table 2.
The correlation between ATP13A2 expression and clinicopathological factors of patients with colon cancer was used in this study
| Feature | ATP13A2 | P | |
|---|---|---|---|
| Low (n = 52) | High (n = 47) | ||
| Gender | P = 0.948 | ||
| Male | 28 | 25 | |
| Female | 24 | 22 | |
| Age at diagnosis | P=0.992 | ||
| < 60 | 10 | 9 | |
| ≥ 60 | 42 | 38 | |
| Invasive depth | P = 0.451 | ||
| Submucosa | 1 | 0 | |
| Muscular layer | 4 | 2 | |
| Serous layer | 42 | 36 | |
| Whole layer | 5 | 9 | |
| Location | P = 0.287 | ||
| Left | 31 | 23 | |
| Right | 21 | 24 | |
| T stage | P = 0.174 | ||
| T1–3 | 47 | 38 | |
| T4 | 5 | 9 | |
| N stage | P = 0.019 | ||
| N0 | 38 | 23 | |
| N1-2 | 14 | 24 | |
| M stage | P = 0.618 | ||
| M0 | 50 | 46 | |
| M1 | 2 | 1 | |
| Histological grade | P = 0.196 | ||
| Well | 3 | 4 | |
| Moderate | 22 | 21 | |
| Poor | 27 | 22 | |